Skip to content

Protein Supplements in Association With Prehabilitation Program for Cancer Patients Before Surgery

Suppléments protéinés en Association d'un Programme de préhabilitation Avant la Prise en Charge Chirurgicale d'un Cancer

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04812704
Enrollment
2
Registered
2021-03-24
Start date
2021-03-09
Completion date
2022-04-30
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Prehabilitation, Surgery

Brief summary

The aim of study is to analyse the feasibility of the use of nutritionnal complements after exercices before surgery for cancer. Body composition, muscle function and muscle mass will be analyse too.

Detailed description

A prospective study will be carried out including adult patients with neoplasia who should benefit in their therapeutic strategy from oncological surgery. About fifty patients will be recruited in the oncology / surgery department at the Saint-Luc University Clinics in Brussels. Patients will be assessed at the initial consultation and after the pre-habilitation period, ie the day before the operation. Dietary monitoring will be carried out in parallel with a physical and respiratory preparation program (prehabilitation) and the intake of protein nutritional supplements in the form of powder to be diluted will be carried out after each exercise session.

Interventions

DIETARY_SUPPLEMENTWhey protein

Patient receive protein supplement in liquid form after each exercice session

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient with operable cancer * patient inform consent * min 18 years old * french or english speaking

Exclusion criteria

* neuromuscular pathology * cardiorespiratory or orthopedic pathology that prevents physical activity * cognitive or psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Adhesion rate of the use of nutritionnel complements after exercices before surgery for cancer3 weeksThe feasibility of this outcome will be assess by the adhesion rate : (number of protein shots taken) / (number of protein shots prescribed). The adhesion will be validated if\> 75% of the holds are respected.

Secondary

MeasureTime frameDescription
Muscle functionOnce at the inclusion and once the day before surgery (3 weeks)This variable will be studied by the 6-minutes walk test (meters)
Nutritional biological markersOnce at the inclusionThese variables will be studied by: prealbumin (g/L) and albumin (g/L) measures
Antropometric markers - heightOnce at the inclusion and once the day before surgery (3 weeks)Height (meters)
Body composition (lean and fat mass)Once at the inclusion and once the day before surgery (3 weeks)Evaluated by an impedancemetry balance : pourcentage of lean and fat mass
Antropometric markers - weightOnce at the inclusion and once the day before surgery (3 weeks)Weight (kilograms)
Antropometric markers - BMIOnce at the inclusion and once the day before surgery (3 weeks)BMI (kg/m²) :weight and height will be combined to report BMI in kg/m²
Muscle strengthOnce at the inclusion and once the day before surgery (3 weeks)This variable will be studied by the hand grip test (kilograms)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026